RTP-026
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RTP-026, covering 2025-09-22 to 2025-09-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI) [Phase 2]